Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum

Tran Nguyen-Ho-Bao1,2, Lum A Ambe3,4, Maxi Berberich1

  • 1Centre for Infectious Medicine, Institute of Parasitology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany.

Insights

Researchers enhanced Nitazoxanide (NTZ) efficacy against cryptosporidiosis by coupling it with octaarginine (R8). This strategy improved drug activity, offering a promising new approach for treating this intestinal disease.

Area of Science:

  • Parasitology
  • Drug Discovery
  • Biotechnology

Background:

  • Cryptosporidiosis is a significant intestinal disease affecting humans and animals, with limited treatment options.
  • Nitazoxanide (NTZ) is the sole FDA-approved drug, but its efficacy is restricted in certain populations.
  • Developing novel therapeutic strategies is crucial due to the lack of vaccines and limited drug effectiveness.

Purpose of the Study:

  • To evaluate the potential of cell-penetrating peptide (CPP) octaarginine (R8) in enhancing NTZ uptake and efficacy.
  • To investigate the anti-cryptosporidial activity of an NTZ-R8 conjugate.
  • To explore a new strategy for improving anti-cryptosporidial therapeutics.

Main Methods:

  • Synthetically attaching octaarginine (R8) to Nitazoxanide (NTZ) via an enzymatically releasable linker.
  • Assessing the efficacy of the NTZ-R8 conjugate against Cryptosporidium parvum growth in vitro.
  • Utilizing a human ileocecal adenocarcinoma (HCT-8) cell line for the culture system.

Main Results:

  • A significant, concentration-dependent increase in drug efficacy was observed with the NTZ-R8 conjugate.
  • Octaarginine (R8) successfully enhanced the uptake and activity of Nitazoxanide (NTZ).
  • The conjugate demonstrated improved inhibition of Cryptosporidium parvum growth in the in vitro model.

Conclusions:

  • Coupling octaarginine (R8) to Nitazoxanide (NTZ) is beneficial for enhancing anti-cryptosporidial drug activity.
  • This strategy represents a promising approach to expand therapeutic options for cryptosporidiosis.
  • Further in vivo studies are warranted to fully characterize the potential of this conjugate drug.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.7K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.1K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
200
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
539
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
155
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
315